AAV Gene Therapy Platform
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
58
NCT06918366
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Inhaled XQ-001 in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 1, 2024
Completion: May 30, 2025
Loading map...